Clinical peptidomic analysis by a one-step direct transfer technology: Its potential utility for monitoring of pathophysiological status in female reproductive system disorders

• Published in: The journal of obstetrics and gynaecology research Vol. 39; no. 10; pp. 1440 - 1448
• Main Authors: Araki, Yoshihiko, Nonaka, Daisuke, Hamamura, Kensuke, Yanagida, Mitsuaki, Ishikawa, Hitoshi, Banzai, Michio, Maruyama, Mayuko, Endo, Shuichiro, Tajima, Atsushi, Lee, Lyang-Ja, Nojima, Michio, Takamori, Kenji, Yoshida, Koyo, Takeda, Satoru, Tanaka, Kenji
• Format: Journal Article
• Language: English
• Published: Australia Blackwell Publishing Ltd 01.10.2013
• Subjects: BLOTCHIP analysis; clinical biomarker; Female; Genital Diseases, Female - metabolism; Genital Diseases, Female - physiopathology; Humans; Hypertension, Pregnancy-Induced - metabolism; peptidome; pregnancy-induced hypertension; Proteomics - trends; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Technology Transfer; peptidome; pregnancy-induced hypertension; BLOTCHIP analysis; clinical biomarker
• ISSN: 1341-8076; 1447-0756
• DOI: 10.1111/jog.12140

To date, numerous studies have searched for candidate molecules or clinical examination methods as potential biomarkers for monitoring intractable diseases, such as carcinomas. Evidence accumulated over the past decade shows that many proteolytic peptides appear in human humoral fluids, including peripheral blood, in association with an individual's health condition. Although an analysis of the whole peptide (the ‘peptidome’) using mass spectrometry is thought to be one of the most powerful and promising experimental approaches, it has failed to identify biomarkers in the clinical blood samples, presumably due to the methodological limitations. In general, commonly used techniques for proteomic analysis of blood require the removal of large amounts of serum/plasma proteins prior to mass spectrometry analysis, and this step seems to have resulted in the overlooking of important biomarkers during the analytical process. Here, we provide a brief overview of a new quantitative peptidomic analysis by a one‐step direct transfer technology without depletion of major blood proteins. Using this technology, we herein report experimental data on serum peptidomic analysis for patients with pregnancy‐induced hypertension as a clinical model. In addition, we refer to the potential utility of this approach for the monitoring of pathophysiological status in female reproductive system disorders in general.